Navigation Links
Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
Date:3/3/2008

ypertensive drug candidates

-- Euro 0.3 million corresponding to the allocation of the remaining

balance of the US$2 million license and option payments received from

Axcan following the termination of the development of NCX 1000 in May

2007

The initial March 2006 payments from Pfizer and Merck listed above were deferred over the estimated duration of NicOx' involvement in the research and development programs provided for under the terms of the corresponding agreements. The terms surrounding the duration of NicOx' involvements in these programs are revised periodically, if necessary. The payments received from Pfizer for the funding of the research activities are deferred over a period of 12 months from the date of invoice.

Operating expenses

Consolidated operating expenses totaled euro 57.8 million in 2007, compared to euro 36.3 million in 2006, of which, 80.4% were attributable to research and development expenses and 19.6% to selling and administrative expenses during 2007, compared to 78.7% and 21.3%, respectively in 2006.

Research and development expenses reached euro 46.5 million in 2007, compared to euro 28.6 million in 2006 (including euro 2.2 million allocated to cost of sales in 2007 and euro 1.6 million in 2006). These expenses are primarily due to the costs associated with the phase 3 development of naproxcinod, such as expenses related to contract research organizations and suppliers involved in naproxcinod's clinical development and manufacturing activities. At this time, the cost of sales principally corresponds to the expenses incurred by NicOx in performing research activities under the contracts signed with Pfizer and Merck. Operational subsidies from the research tax credit, which are deducted from research and development expenses, amounted to euro 3.9 million in 2007 compared to euro 1.2 million in 2006. On December 31, 2007, the Company employed 84 people in research and development
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
3. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
4. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
5. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
6. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
7. Biopure Announces 2007 Third Quarter Financial Results
8. Xytis Names Gordon H. Busenbark as Chief Financial Officer
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Pharmacopeia Announces Third Quarter 2007 Financial Results
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015 As of February, ... incontinence devices for women. "Shipping thousands ... gratifying part is the hundreds of letters, emails ... lives have been positively impacted by our technology," ... InControl recently released Apex, an over-the-counter ...
(Date:3/27/2015)... DALLAS , March 27, 2015   ... global leader in biosimilars and the world,s leading ... two studies that support an evaluation of biosimilarity ... U.S. Food and Drug Administration (FDA) conditionally approved ... Amgen,s EPOGEN™ (epoetin alfa). These study data were ...
(Date:3/27/2015)... NEW BRUNSWICK, N.J. , March 27, 2015  Johnson ... Meeting of Shareholders at 10 a.m. (Eastern Time) on Thursday, ... New Brunswick, N.J. Investors and other ... meeting by visiting the Company,s website at www.jnj.com ... of presentations from the meeting will be made available a ...
Breaking Medicine Technology:InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
... , MINNETONKA, Minn., Dec. 1 ... company specializing in clinical study management systems, today ... technology solution, has been certified by the Clinical ... the Operational Data Model (ODM) standard. This ...
... , CAMBRIDGE, Mass. and TOKYO, Dec. 1 Galenea ... further extension of their research and development collaboration through ... to seven years and brings the total committed funding ... working together since January 2005 with the goal of ...
Cached Medicine Technology:MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3
(Date:3/27/2015)... New York, NY (PRWEB) March 27, 2015 ... is seeing more plastic surgery patients travel to the ... Tania Medina. The plastic surgery clinic is turning the ... for international cosmetic surgery patients — with trustworthy services ... important factor when selecting a plastic surgeon. Patients are ...
(Date:3/27/2015)... 27, 2015 The report “CountryFocus ... an essential source of information on and analysis ... Germany. Germany’s increasingly elderly population and its associated ... market. In 2013, the elderly accounted for 27.1% ... Compound Annual Growth Rate (CAGR) of 1.2% to ...
(Date:3/27/2015)... UK (PRWEB) March 27, 2015 DrugDev ... Melissa (Liss) Easy was named to the 2015 Philadelphia ... Under 40 list spotlights 40 dynamic, up-and-coming leaders less ... and community involvement. Winners are honored at an awards ... of the Philadelphia Business Journal. , Lyn Kremer, Publisher ...
(Date:3/27/2015)... According to Health Day , on March ... Syndrome (NAS) are causing alarm for Florida officials. Infants ... for a month of their lives- and can experience ... The condition is precipitated by drug use during pregnancy. ... employing medically assisted drug treatment) will also inflict NAS ...
(Date:3/27/2015)... California’s ongoing worst ever drought, and ... the United States Northeast, are both manifestations of the ... is creating changes in the atmosphere’s “energy balance,” according ... NASA researcher, speaking on the Sharon Kleyne Hour™ Power ... a warmer and dryer global climate but also greater ...
Breaking Medicine News(10 mins):Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 2Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 3Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 2Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 3Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 4Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 3
... significant growth to the ... company,s first aid division, ... DSCI) announced today that it has secured two,additional licenses to ... popular and growing segment of printed,bandages allows for distribution of ...
... Deployed in "A Strategy of Home Telehealth for the Management ... ... Minneapolis (PRWEB) October 28, 2008 -- American TeleCare, Inc. ... monitoring and video-based telehealth solutions, announced that its InLife™ and ...
... American Society of Plastic Surgeons Annual Meeting, CHICAGO, ... Air resident, a burn victim from an accident in ... of special needs,will be the proud recipient of the ... American Society of Plastic Surgeons (ASPS) Plastic,Surgery 2008 conference, ...
... As Americans curtail spending to,offset economic challenges, they,re ... proven to provide an invaluable service despite,the shaky ... stroller,exercise program for new moms found in over ... losing clients," explains Rachel Pustilnik, owner,of the Richmond, ...
... ULURU Inc. (Amex:,ULU) today announced that it will present ... and Wound Care" being held in Las Vegas from,October ... on the poster titled, "Altrazeal(TM), A,Transforming Powder Wound Dressing: ... M.D., FACHM, FAPWCA, Director of the Centers,for Comprehensive Wound ...
... Web Site, Hosts "Visit Day",at APHA Annual Convention Exhibition ... is facing a major public,health workforce crisis - and ... all if action is not taken to recruit more ... of Schools of,Public Health (ASPH) completed an assessment of ...
Cached Medicine News:Health News:Derma Sciences Announces 3-Year Licensing Deals for Highly Profitable Character Strip Bandages 2Health News:Telehealth Solutions from American TeleCare, Inc. Support Heart Failure Management Study in Canada 2Health News:Telehealth Solutions from American TeleCare, Inc. Support Heart Failure Management Study in Canada 3Health News:Telehealth Solutions from American TeleCare, Inc. Support Heart Failure Management Study in Canada 4Health News:Baltimore Local, Burn Victim Wins Patient of Courage Award 2Health News:Stroller Strides(R) Franchises Succeed Despite Economic Climate 2Health News:ULURU Inc. Announces Poster Presentations at the 23rd Annual 'Clinical Symposium on Advances in Skin & Wound Care' 2Health News:ULURU Inc. Announces Poster Presentations at the 23rd Annual 'Clinical Symposium on Advances in Skin & Wound Care' 3Health News:ASPH and APHA Collaborate to Shore up the Public Health Workforce Pipeline: 2Health News:ASPH and APHA Collaborate to Shore up the Public Health Workforce Pipeline: 3
... safe care environment by automatically bar code printing ... level. The automated process and reliable bar codes ... of all items, including vials, ampules, syringes, IV ... saves valuable time for pharmacy staff and helps ...
wBloodCare™ provides functionality at the bedside to ensure that the correct patient receives the correct blood product....
Specimen-ID™, a Positive Specimen Identification System, assures the permanent link at the bedside between patient and laboratory specimen to prevent sample identification errors....
wCareMed™ utilizes barcode scanning technology to support medication administration. It is a simple to use point of care application that provides access to patient information on a lightweight,...
Medicine Products: